A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT00481091 · COMPLETED
Trial details
- NCT number
- NCT00481091
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-25
- Primary completion
- 2022-05-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.